Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$10.05 - $12.02 $428,572 - $512,580
-42,644 Reduced 56.69%
32,583 $346 Million
Q1 2024

May 13, 2024

SELL
$11.27 - $13.53 $1.4 Million - $1.69 Million
-124,660 Reduced 62.37%
75,227 $898 Million
Q4 2023

Feb 12, 2024

BUY
$8.77 - $10.85 $1.75 Million - $2.17 Million
199,887 New
199,887 $2.16 Billion

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Clear Alpha Technologies LP Portfolio

Follow Clear Alpha Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Alpha Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Clear Alpha Technologies LP with notifications on news.